Growth
Growth/Value/Cyclicals
Value strong again in Q2.
Momentum & Growth Factors Regain Footing
But Momentum turnover of constituents has altered its characteristics – names are now slightly more defensive, cheaper, and larger.
Growth/Value/Cyclicals
Growth outperformed Value in all market cap subsets: Large Cap, Mid Cap, and Small Cap. It also snapped a five month losing streak with Cyclicals. Despite the reversal, Growth is still lagging YTD, and is extremely undervalued compared to Value.
Growth/Value/Cyclicals
In April, Large Cap Value widened its YTD outperformance over Large Growth to 730 bps.
Quantitative Strategies: Factor Performance Reverses
Momentum suffered across almost every sector, but it was particularly bad for Health Care and Info Tech. Value factors finally rebounded after losing over the past year.
Growth/Value/Cyclicals
Growth Takes It On The Chin In March.
The State Of Momentum
Momentum has easily been the best quantitative factor over the last year. The only other factor with notable positive performance is Sentiment. Can this continue?
Growth/Value/Cyclicals
Growth Outperforms Value In February.
Growth/Value/Cyclicals
Small Cap Growth Outperforms (On Relative Basis) In Down Month
Growth/Value/Cyclicals
Growth Stocks Best In All Three Cap Categories.
Group Scores Worked Well In 2013, What We Like For 2014
All five factor categories did well, and the best performing Attractive industries came from six different sectors and ranged from traditionally defensive to more cyclical groups.
Dissecting The Capital Tier Indices
Sector weight changes during November were minimal.
Growth/Value/Cyclicals Market Internals
Growth Stocks Lead YTD In All Three Cap Categories.
Large Cap Growth Bounces Back The Past Two Months
Growth stocks are now all above their historical average valuation levels. Value stocks are all solidly overvalued compared to their recorded averages.
Growth Continues Leading In Mid And Small Caps YTD, Large Cap Growth Bounces Back
All three cap tiers of Growth also now ahead for the YTD. Growth stocks are moving towards their his- torical average valuation levels, with Mid Cap Growth now being overvalued. All Value stock segments continue to be solidly overvalued.
Earnings Momentum - Q2 Reports Below Average But Ahead Of Q1
With all three months of Q2 earnings reports in, the 1.28 ratio is much stronger than Q1, but remains below the 1.51 historical average ratio.
Growth Continues Leading In Mid And Small Caps YTD But Lags In Large Caps
Growth’s leadership over Value has only been apparent in Large Caps, but this segment had a big short-term reversal in recent months. Large Cap Cyclicals (+7%) significantly lag Large Cap Growth (+17%) YTD.
Duration: It’s Not Just For Bonds Anymore
We measure the sensitivity of common stocks to changes in interest rates using Implied Equity Duration. Growth-oriented sectors tend to have higher duration than Value-oriented sectors, while regional differences are largely explained by interest rate and risk premium differentials.
Dissecting The Capital Tier Indices
Consumer Discretionary’s weight increased the most in the S&P 500, rising 0.5%. Health Care rose the most in Mid Caps (+0.3%), while Information Technology rose the most in Small Caps (+0.7%).
Growth Leads In Mid And Small Caps But Lags In Large Caps
Growth’s longer term trend of leadership over Value has only been apparent in Large Caps, but this segment had a big short-term reversal in Q2 and July.